Comparison of follicular fluid and serum anti-Mullerian hormone levels as predictors of the outcome of assisted reproductive treatment
- 1 July 2013
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 169 (2) , 252-256
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Anti-Mullerian hormone (AMH): what do we still need to know?Human Reproduction, 2009
- Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injectionFertility and Sterility, 2008
- Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapyHuman Reproduction, 2007
- Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphologyHuman Reproduction, 2005
- Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular statusFertility and Sterility, 2005
- Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitmentMolecular Human Reproduction, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Serum anti-Mullerian hormone levels: a novel measure of ovarian reserveHuman Reproduction, 2002
- Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cyclesFertility and Sterility, 2002
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002